"Triple Threat" Conditions Predict Mortality Among Patients With Advanced Cancer Who Present to the Emergency Department.

delirium dyspnea emergency department mortality poor performance status prognosis symptoms triple threat

Journal

The Journal of emergency medicine
ISSN: 0736-4679
Titre abrégé: J Emerg Med
Pays: United States
ID NLM: 8412174

Informations de publication

Date de publication:
09 2022
Historique:
received: 22 01 2021
revised: 19 04 2022
accepted: 09 05 2022
pubmed: 12 10 2022
medline: 18 11 2022
entrez: 11 10 2022
Statut: ppublish

Résumé

Delirium, poor performance status, and dyspnea predict short survival in the palliative care setting. Our goal was to determine whether these three conditions, which we refer to as a "triple threat," also predict mortality among patients with advanced cancers in the emergency department (ED). The study sample included 243 randomly selected, clinically stable patients with advanced cancer who presented to our ED. The analysis included patients who had delirium (Memorial Delirium Assessment Scale score ≥ 7), poor performance status (Eastern Cooperative Oncology Group performance status score of 3 or 4), or dyspnea as a presenting symptom. We obtained survival data from medical records. We calculated predicted probability of dying within 30 days and association with number of symptoms after the ED visit using logistic regression analysis. Twenty-eight patients died within 30 days after presenting to the ED. Death within 30 days occurred in 36% (16 of 44) of patients with delirium, 28% (17 of 61) of patients with poor performance status, and 14% (7 of 50) of patients with dyspnea, with a predicted probability of 30-day mortality of 0.38 (95% confidence interval [CI] 0.25-0.53), 0.28 (95% CI 0.18-0.40), and 0.15 (95% CI 0.07-0.29), respectively. The predicted probability of death within 30 days for patients with two or three of the conditions was 0.49 (95% CI 0.34-0.66) vs. 0.05 (95% CI 0.02-0.09) for patients with none or one of the conditions. Patients with advanced cancers who present to the ED and have at least two triple threat conditions have a high probability of death within 30 days.

Sections du résumé

BACKGROUND
Delirium, poor performance status, and dyspnea predict short survival in the palliative care setting.
OBJECTIVE
Our goal was to determine whether these three conditions, which we refer to as a "triple threat," also predict mortality among patients with advanced cancers in the emergency department (ED).
METHODS
The study sample included 243 randomly selected, clinically stable patients with advanced cancer who presented to our ED. The analysis included patients who had delirium (Memorial Delirium Assessment Scale score ≥ 7), poor performance status (Eastern Cooperative Oncology Group performance status score of 3 or 4), or dyspnea as a presenting symptom. We obtained survival data from medical records. We calculated predicted probability of dying within 30 days and association with number of symptoms after the ED visit using logistic regression analysis.
RESULTS
Twenty-eight patients died within 30 days after presenting to the ED. Death within 30 days occurred in 36% (16 of 44) of patients with delirium, 28% (17 of 61) of patients with poor performance status, and 14% (7 of 50) of patients with dyspnea, with a predicted probability of 30-day mortality of 0.38 (95% confidence interval [CI] 0.25-0.53), 0.28 (95% CI 0.18-0.40), and 0.15 (95% CI 0.07-0.29), respectively. The predicted probability of death within 30 days for patients with two or three of the conditions was 0.49 (95% CI 0.34-0.66) vs. 0.05 (95% CI 0.02-0.09) for patients with none or one of the conditions.
CONCLUSIONS
Patients with advanced cancers who present to the ED and have at least two triple threat conditions have a high probability of death within 30 days.

Identifiants

pubmed: 36220672
pii: S0736-4679(22)00327-4
doi: 10.1016/j.jemermed.2022.05.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

355-362

Informations de copyright

Published by Elsevier Inc.

Auteurs

Ahmed F Elsayem (AF)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Carla L Warneke (CL)

Department of Statistics, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Cielito C Reyes-Gibby (CC)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Luke J Buffardi (LJ)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Humaira Sadaf (H)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Patrick S Chaftari (PS)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Patricia A Brock (PA)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Valda D Page (VD)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Jayne Viets-Upchurch (J)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Demis Lipe (D)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Kumar Alagappan (K)

Department of Emergency Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH